Literature DB >> 7864737

The optic neuritis treatment trial: three-year follow-up results.

R W Beck.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7864737     DOI: 10.1001/archopht.1995.01100020014004

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


× No keyword cloud information.
  22 in total

Review 1.  Physicians, subsequence and consequence.

Authors:  W I McDonald
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-09       Impact factor: 10.154

Review 2.  Corticosteroids for treating optic neuritis.

Authors:  Robin L Gal; Satyanarayana S Vedula; Roy Beck
Journal:  Cochrane Database Syst Rev       Date:  2015-08-14

Review 3.  Corticosteroids for treating optic neuritis.

Authors:  S S Vedula; S Brodney-Folse; R L Gal; R Beck
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

Review 4.  Corticosteroids and plasma exchange in multiple sclerosis.

Authors:  Hayretin Tumani
Journal:  J Neurol       Date:  2008-12       Impact factor: 4.849

5.  [Multiple sclerosis. An update with practical guidelines for ophthalmologists].

Authors:  T Ziemssen; H Wilhelm; F Ziemssen
Journal:  Ophthalmologe       Date:  2006-07       Impact factor: 1.059

6.  Adherence to Clinical Trial Supported Evaluation of Optic Neuritis.

Authors:  Elana Meer; Kenneth S Shindler; Yinxi Yu; Brian L VanderBeek
Journal:  Ophthalmic Epidemiol       Date:  2019-05-29       Impact factor: 1.648

Review 7.  Investigation of visual loss: neuro-ophthalmology from a neurologist's perspective.

Authors:  C J Lueck
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-03       Impact factor: 10.154

Review 8.  Corticosteroids for treating optic neuritis.

Authors:  Robin L Gal; Satyanarayana S Vedula; Roy Beck
Journal:  Cochrane Database Syst Rev       Date:  2012-04-18

9.  Clinical approach to optic neuropathies.

Authors:  Raed Behbehani
Journal:  Clin Ophthalmol       Date:  2007-09

Review 10.  Pediatric multiple sclerosis.

Authors:  Dorothée Chabas; Ari J Green; Emmanuelle Waubant
Journal:  NeuroRx       Date:  2006-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.